TOP-10+ Vitamininfusionen Therapeuten in der Türkei 2024

Hausarzt/-in

12 Jahre der Erfahrung

Türkei, Istanbul

Veysel OZCAN Klinik

Veysel Ozcan

Hausarzt/-in

12 Jahre der Erfahrung

The doctor, who has 12 years of experience, previously worked in aesthetic clinics in Nişantaşı and Bakırköy. The doctor, who also has 2 years of experience as a chief physician, can speak good English and intermediate Kurdish.

He has certificates approved by the Turkish Ministry of Health in the fields of Mesotherapy, Phytotherapy, Cupping Therapy and Ozone Therapy.

He is a disciplined, innovative and perfectionist physician. Good communication, focused on patient satisfaction.

He served as the chairman of the Infection Committee, Quality Unit, Inspection Commission, Facility Security and Patient Safety at the State Hospital.

The doctor, who has 12 years of experience, previously worked in aesthetic clinics in Nişantaşı and Bakırköy. The doctor, who also has 2 years of experience as a chief physician, can speak good English and intermediate Kurdish.

He has certificates approved by the Turkish Ministry of Health in the fields of Mesotherapy, Phytotherapy, Cupping Therapy and Ozone Therapy.

He is a disciplined, innovative and perfectionist physician. Good communication, focused on patient satisfaction.

He served as the chairman of the Infection Committee, Quality Unit, Inspection Commission, Facility Security and Patient Safety at the State Hospital.

All-Inclusive Paketpreis:

Botox, Hautfüller, Mesotherapie, PRP

$236

Einzelheiten

Kostenlose Beratung erhalten Informationen

Esra Ozbasli

Frauenarzt/-in-Gynäkologe

21 Jahre der Erfahrung

Türkei, Istanbul

Assoc. Prof. Dr. Esra Özbaşlı OBGYN & Genital Aesthetics

Esra Ozbasli

Frauenarzt/-in-Gynäkologe

21 Jahre der Erfahrung

I am Assoc. Prof. Dr. Esra Ozbasli, a board-certified OB-GYN and Genital Cosmetic Surgeon with over 21 years of experience. My dedication to excellence and patient satisfaction has established our clinic as a trusted destination for women’s health and aesthetic procedures in Nişantaşı, heart of Istanbul.I received my medical degree from Istanbul University Cerrahpaşa Medical Faculty, followed by specialized training in obstetrics and gynecology at Istanbul Zeynep Kamil Women and Children Diseases Training and Research Hospital. After working as an academician at Acıbadem University for 12 years, I became an associate professor there by exhibiting my scientific articles in many respected international scientific journals published in Pubmed. During this period, I trained many medical students and OBGYN specialist colleagues in the field of genital aesthetics surgery, urogyneacology. My advanced training in genital cosmetic surgery provided me with expertise in the latest techniques for enhancing and restoring female genital aesthetics and function. I hold certifications in Genital Aesthetics and Cosmetic Gynecology (Vaginal Rejuvenation), Certificate of da Vinci System Training as a Console Surgeon (since 2013) and the ECFMG certificate for foreign medical graduates. Additionally, I possess advanced-level English proficiency (TOEFL score 600 in 2003), ensuring clear communication with international patients. I have completed an observership in New York University in 2005.

Specialized Services:

• Genital Cosmetic Surgery: Labioplasty, hudoplasty, vaginoplasty, lipofilling, PRP therapy, hyaluronic acid filling, hymenoplasty, labia majora plasty, vulvar whitening, G-shot, O-shot, treatment of atrophic vagina, lichen sclerosis, and vaginal laxity.

• Minimally Invasive Surgery: Laparoscopy, robotic surgery, hysteroscopy for fibroids, endometrioma, endometrial polyps, ovarian cysts, tubal ligation, intrauterine septum resection, abnormal vaginal bleeding, and hysterectomy.

• Menopause Treatment: Bioidentical hormone therapy for managing menopausal symptoms, mezotherapy and laser for atrophic vagina.

•Urinary incontinence treatment: Sling operations (TOT), hyaluronic acid filling, laser treatments.

• Cervical Dysplasia Diagnosis and Treatment: Co-test, PAP-smear, colposcopy guided biopsy and LEEP conization.

International Patient Services:

We offer a package service for our foreign patients that includes:

• Arrangements for flights and hotel stays • Pick-up service from the airport and hotel • Assistance throughout your stay to ensure a smooth and stress-free experience • Sightseeing of Istanbul before the surgery if requested

Why Choose Us:

• Expertise: With over two decades of specialized experience, I offer advanced surgical techniques and personalized care.

• Innovation: Utilizing the latest technology in minimally invasive and cosmetic procedures to ensure optimal results.

• Quality Care: I perform my surgeries in A-class hospitals equipped with advanced technological surgical devices.

• Compassion: Committed to providing a comfortable, supportive, and private environment for all patients.

I am Assoc. Prof. Dr. Esra Ozbasli, a board-certified OB-GYN and Genital Cosmetic Surgeon with over 21 years of experience. My dedication to excellence and patient satisfaction has established our clinic as a trusted destination for women’s health and aesthetic procedures in Nişantaşı, heart of Istanbul.I received my medical degree from Istanbul University Cerrahpaşa Medical Faculty, followed by specialized training in obstetrics and gynecology at Istanbul Zeynep Kamil Women and Children Diseases Training and Research Hospital. After working as an academician at Acıbadem University for 12 years, I became an associate professor there by exhibiting my scientific articles in many respected international scientific journals published in Pubmed. During this period, I trained many medical students and OBGYN specialist colleagues in the field of genital aesthetics surgery, urogyneacology. My advanced training in genital cosmetic surgery provided me with expertise in the latest techniques for enhancing and restoring female genital aesthetics and function. I hold certifications in Genital Aesthetics and Cosmetic Gynecology (Vaginal Rejuvenation), Certificate of da Vinci System Training as a Console Surgeon (since 2013) and the ECFMG certificate for foreign medical graduates. Additionally, I possess advanced-level English proficiency (TOEFL score 600 in 2003), ensuring clear communication with international patients. I have completed an observership in New York University in 2005.

Specialized Services:

• Genital Cosmetic Surgery: Labioplasty, hudoplasty, vaginoplasty, lipofilling, PRP therapy, hyaluronic acid filling, hymenoplasty, labia majora plasty, vulvar whitening, G-shot, O-shot, treatment of atrophic vagina, lichen sclerosis, and vaginal laxity.

• Minimally Invasive Surgery: Laparoscopy, robotic surgery, hysteroscopy for fibroids, endometrioma, endometrial polyps, ovarian cysts, tubal ligation, intrauterine septum resection, abnormal vaginal bleeding, and hysterectomy.

• Menopause Treatment: Bioidentical hormone therapy for managing menopausal symptoms, mezotherapy and laser for atrophic vagina.

•Urinary incontinence treatment: Sling operations (TOT), hyaluronic acid filling, laser treatments.

• Cervical Dysplasia Diagnosis and Treatment: Co-test, PAP-smear, colposcopy guided biopsy and LEEP conization.

International Patient Services:

We offer a package service for our foreign patients that includes:

• Arrangements for flights and hotel stays • Pick-up service from the airport and hotel • Assistance throughout your stay to ensure a smooth and stress-free experience • Sightseeing of Istanbul before the surgery if requested

Why Choose Us:

• Expertise: With over two decades of specialized experience, I offer advanced surgical techniques and personalized care.

• Innovation: Utilizing the latest technology in minimally invasive and cosmetic procedures to ensure optimal results.

• Quality Care: I perform my surgeries in A-class hospitals equipped with advanced technological surgical devices.

• Compassion: Committed to providing a comfortable, supportive, and private environment for all patients.

Kostenlose Beratung erhalten Informationen

Gorkem Oruc Adali

Dermatologe/-in

9 Jahre der Erfahrung

Türkei, Istanbul

EMPCLINICS

Gorkem Oruc Adali

Dermatologe/-in

9 Jahre der Erfahrung

“As a dermatologist, I am interested in aesthetic, cosmetic procedures and dermatologic surgery. I have improved myself in the trainings, courses and congresses I attended during my residency and specialization period. I want to work in these areas in the position I aim to work.”

Education Status

Başakşehir Çam and Sakura City Hospital, Department of Dermatology, Resident Physician: October 2020 - June 2022 (observer assistant between October 2020 - March 2021)

Department of Dermatology, Kiev Medical University (Ukraine), Resident Physician: March 2018 - March 2021

Kocaeli University Faculty of Medicine: 2009-2015

Kadıköy Anatolian High School: 2004-2009 (1+4 years of normal education)

Tunbridge Wells High School 2005-2006 (2 years, UK)

Private Yüzyıl Işıl Primary School 1997-2004

Work Experience

Sakarya University Training and Research Hospital, Department of Dermatology, Specialist Physician: June 2022 - Currently

Başakşehir Çam and Sakura City Hospital, Department of Dermatology, Resident Physician: October 2020 - June 2022 (observer assistant between October 2020 - March 2021)

International Multi-Profile Clinic (Private Clinic), Dermatology, Kiev, Ukraine 2018 - 2020

Department of Dermatology, Kiev Medical University (Ukraine), Resident Physician: March 2018 - March 2021

Kocaeli, Karamürsel Family Medicine: 2016 - 2018

Gölcükspor Football Club Team Doctor 2016 - 2018

Kocaeli Kartepe Racecourse, Emergency Physician: 2016 - 2018

Kocaeli Gölcük District Health Directorate: 2016

Erzurum Tekman State Hospital, Emergency Department 2015 - 2016

Foreign Language

 English - Advanced

 Russian - Intermediate

“As a dermatologist, I am interested in aesthetic, cosmetic procedures and dermatologic surgery. I have improved myself in the trainings, courses and congresses I attended during my residency and specialization period. I want to work in these areas in the position I aim to work.”

Education Status

Başakşehir Çam and Sakura City Hospital, Department of Dermatology, Resident Physician: October 2020 - June 2022 (observer assistant between October 2020 - March 2021)

Department of Dermatology, Kiev Medical University (Ukraine), Resident Physician: March 2018 - March 2021

Kocaeli University Faculty of Medicine: 2009-2015

Kadıköy Anatolian High School: 2004-2009 (1+4 years of normal education)

Tunbridge Wells High School 2005-2006 (2 years, UK)

Private Yüzyıl Işıl Primary School 1997-2004

Work Experience

Sakarya University Training and Research Hospital, Department of Dermatology, Specialist Physician: June 2022 - Currently

Başakşehir Çam and Sakura City Hospital, Department of Dermatology, Resident Physician: October 2020 - June 2022 (observer assistant between October 2020 - March 2021)

International Multi-Profile Clinic (Private Clinic), Dermatology, Kiev, Ukraine 2018 - 2020

Department of Dermatology, Kiev Medical University (Ukraine), Resident Physician: March 2018 - March 2021

Kocaeli, Karamürsel Family Medicine: 2016 - 2018

Gölcükspor Football Club Team Doctor 2016 - 2018

Kocaeli Kartepe Racecourse, Emergency Physician: 2016 - 2018

Kocaeli Gölcük District Health Directorate: 2016

Erzurum Tekman State Hospital, Emergency Department 2015 - 2016

Foreign Language

 English - Advanced

 Russian - Intermediate

Kostenlose Beratung erhalten Informationen

Mustafa Tumturk

Dermatologe/-in

15 Jahre der Erfahrung

5.0

47 Rezensionen

Türkei, Istanbul

Health Point World Clinic (former Dr. Soho Clinic)

Mustafa Tumturk

Dermatologe/-in

15 Jahre der Erfahrung

Medical aesthetics is a specialized field of medicine that focuses on improving cosmetic appearance through the treatment of conditions including scars, skin laxity, wrinkles, moles, liver spots, excess fat, cellulite, unwanted hair, skin discoloration and spider veins. In Istanbul, Turkey, medical aesthetics encompasses a broad range of non surgical procedures that aim to enhance an individual’s appearance and boost their self confidence.

Injectables: Including Botox and dermal fillers to reduce the appearance of wrinkles and to plump up the skin.
Laser Treatments: Utilized for hair removal, skin resurfacing, and to diminish the visibility of scars or pigmentation.
Skin Rejuvenation: Such as chemical peels, microneedling, and light therapy to improve skin texture and tone.

Medical aesthetics is a specialized field of medicine that focuses on improving cosmetic appearance through the treatment of conditions including scars, skin laxity, wrinkles, moles, liver spots, excess fat, cellulite, unwanted hair, skin discoloration and spider veins. In Istanbul, Turkey, medical aesthetics encompasses a broad range of non surgical procedures that aim to enhance an individual’s appearance and boost their self confidence.

Injectables: Including Botox and dermal fillers to reduce the appearance of wrinkles and to plump up the skin.
Laser Treatments: Utilized for hair removal, skin resurfacing, and to diminish the visibility of scars or pigmentation.
Skin Rejuvenation: Such as chemical peels, microneedling, and light therapy to improve skin texture and tone.

5.0

47 Rezensionen

Kostenlose Beratung erhalten Informationen

Nazan Taslidere

Dermatologe/-in

29 Jahre der Erfahrung

5.0

28 Rezensionen

Türkei, Istanbul

Florence Nightingale Hospital

Nazan Taslidere

Dermatologe/-in

29 Jahre der Erfahrung

Published journal articles indexed by SCI, SSCI, and AHCI I. Investigation of the effectiveness of teledermatology in the diagnosis of skin lesions in pediatric patients TaslidereN.,KucukO.S. Revista daAssociacaoMedicaBrasileira (1992),vol.69,no.10,2023 (SCI-Expanded) I . Can a Correct Diagnosis Be Established Using the TeledermatologyMethod? TAŞLIDEREN.,SUKÜÇÜKÖ. ACTADERMATOVENEROLOGICACROATICA,vol.30,no.1,pp.32-39,2022 (SCI-Expanded) I I. Melkersson-Rosenthal syndrome induced by COVID-19: A case report TaşlıdereB.,MehmetajL.,ÖzcanA.B.,GülenB.,TaşlıdereN. AmericanJournalofEmergencyMedicine,vol.41,2021 (SCI-Expanded) IV. Which dermatology patients attend to Dermatology Outpatient Clinics during the SARS-CoV-2 outbreak in Turkey and what happened to them? CENGİZ F.P.,EMİROĞLUN.,BAHALIA.G.,DİZMAND.,TAŞLIDEREN.,AkarslanT.C.,GunesB.,MERTÖ.,KÜÇÜKÖ.S., ONSUNN. DERMATOLOGICTHERAPY,vol.33,no.4,2020 (SCI-Expanded)

Published journal articles indexed by SCI, SSCI, and AHCI I. Investigation of the effectiveness of teledermatology in the diagnosis of skin lesions in pediatric patients TaslidereN.,KucukO.S. Revista daAssociacaoMedicaBrasileira (1992),vol.69,no.10,2023 (SCI-Expanded) I . Can a Correct Diagnosis Be Established Using the TeledermatologyMethod? TAŞLIDEREN.,SUKÜÇÜKÖ. ACTADERMATOVENEROLOGICACROATICA,vol.30,no.1,pp.32-39,2022 (SCI-Expanded) I I. Melkersson-Rosenthal syndrome induced by COVID-19: A case report TaşlıdereB.,MehmetajL.,ÖzcanA.B.,GülenB.,TaşlıdereN. AmericanJournalofEmergencyMedicine,vol.41,2021 (SCI-Expanded) IV. Which dermatology patients attend to Dermatology Outpatient Clinics during the SARS-CoV-2 outbreak in Turkey and what happened to them? CENGİZ F.P.,EMİROĞLUN.,BAHALIA.G.,DİZMAND.,TAŞLIDEREN.,AkarslanT.C.,GunesB.,MERTÖ.,KÜÇÜKÖ.S., ONSUNN. DERMATOLOGICTHERAPY,vol.33,no.4,2020 (SCI-Expanded)

5.0

28 Rezensionen

Kostenlose Beratung erhalten Informationen

Dr Makbule Dundar

Dermatologe/-in

25 Jahre der Erfahrung

5.0

1 Rezensionen

Türkei, Istanbul

Medipol Acibadem Bezirkskrankenhaus

Dr Makbule Dundar

Dermatologe/-in

25 Jahre der Erfahrung

Professional Experience:

2017 - 2024: SALTAT CLINIC GÖZTEPE BRANCH, Specialist in Dermatology and Venereology

2014 - 2017: MEMORIAL WELLNESS, Specialist in Dermatology and Venereology

2008 - 2014: PRIVATE ISTANBUL MEDIPOL HOSPITAL, Specialist in Dermatology and Venereology

2006 - 2008: MEDICALPARK BAHÇELİEVLER HOSPITAL, Specialist in Dermatology and Venereology

2003 - 2006: TBV SERVICE HOSPITAL, Specialist in Dermatology and Venereology

1999 - 2003: FIZIKOM AESTHETICS AND LASER CENTER, Specialist in Dermatology and Venereology

Education:

1996 - 1999: HASEKI STATE HOSPITAL - Residency in Dermatology

1989 - 1995: ISTANBUL UNIVERSITY, ISTANBUL FACULTY OF MEDICINE, Medical Doctor Training

Professional Experience:

2017 - 2024: SALTAT CLINIC GÖZTEPE BRANCH, Specialist in Dermatology and Venereology

2014 - 2017: MEMORIAL WELLNESS, Specialist in Dermatology and Venereology

2008 - 2014: PRIVATE ISTANBUL MEDIPOL HOSPITAL, Specialist in Dermatology and Venereology

2006 - 2008: MEDICALPARK BAHÇELİEVLER HOSPITAL, Specialist in Dermatology and Venereology

2003 - 2006: TBV SERVICE HOSPITAL, Specialist in Dermatology and Venereology

1999 - 2003: FIZIKOM AESTHETICS AND LASER CENTER, Specialist in Dermatology and Venereology

Education:

1996 - 1999: HASEKI STATE HOSPITAL - Residency in Dermatology

1989 - 1995: ISTANBUL UNIVERSITY, ISTANBUL FACULTY OF MEDICINE, Medical Doctor Training

5.0

1 Rezensionen

Kostenlose Beratung erhalten Informationen

Nail Paksoy

Onkologe/Mammologe/-in

13 Jahre der Erfahrung

5.0

2 Rezensionen

Türkei, Istanbul

Medipol Bahçelievler Hospital

Nail Paksoy

Onkologe/Mammologe/-in

13 Jahre der Erfahrung

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
Role: Subinvestigator

2. PFİZER

Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
Role: Subinvestigator

3. RECITE - AMGEN

Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
Role: Subinvestigator

4. NAVIGATE - BAYER

Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
Role: Subinvestigator

5. RUBY - Tesaro (PRA)

Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
Role: Subinvestigator

7. ASTRA ZENECA

Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
Role: Subinvestigator

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

Authors: Paksoy, Nail, et al.
Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

Authors: HAS SIMSEK, Duygu, et al.
Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

Authors: TURAL, Deniz, et al.
Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

Authors: FERHATOGLU, Ferhat, et al.
Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

Authors: TURAL, Deniz, et al.
Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

Authors: GÜRBÜZ, Mustafa, et al.
Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

Authors: AY, Seval, et al.
Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

Authors: CIL, Ibrahim, et al.
Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

Authors: HIZAL, Mutlu, et al.
Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

Authors: DEMIR, Semra, et al.
Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

Authors: ÖZDEMIR, Seçil Kepil, et al.
Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

Authors: Dogan, I., Paksoy, N., & Basaran, M.
Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

Authors: Dogan, I., Paksoy, N., & Basaran, M.
Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
Role: Subinvestigator

2. PFİZER

Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
Role: Subinvestigator

3. RECITE - AMGEN

Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
Role: Subinvestigator

4. NAVIGATE - BAYER

Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
Role: Subinvestigator

5. RUBY - Tesaro (PRA)

Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
Role: Subinvestigator

7. ASTRA ZENECA

Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
Role: Subinvestigator

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

Authors: Paksoy, Nail, et al.
Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

Authors: HAS SIMSEK, Duygu, et al.
Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

Authors: TURAL, Deniz, et al.
Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

Authors: FERHATOGLU, Ferhat, et al.
Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

Authors: TURAL, Deniz, et al.
Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

Authors: GÜRBÜZ, Mustafa, et al.
Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

Authors: AY, Seval, et al.
Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

Authors: CIL, Ibrahim, et al.
Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

Authors: HIZAL, Mutlu, et al.
Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

Authors: DEMIR, Semra, et al.
Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

Authors: ÖZDEMIR, Seçil Kepil, et al.
Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

Authors: Dogan, I., Paksoy, N., & Basaran, M.
Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

Authors: Dogan, I., Paksoy, N., & Basaran, M.
Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
Journal: Medicine, 102(41), e35245